Luye Pharma Group's total assets for Q2 2026 were ¥34.87B, an increase of 6.18% from the previous quarter. LYPHF total liabilities were ¥16.99B for the fiscal quarter, a 19.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.